Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Avience Biomedicals Annual General Meeting

Avience Biomedicals filed notice of its 7th AGM, set for September 30, 2026, with its FY 2025-26 Annual Report. No monetary transaction is disclosed.

Source

NSE filing, NSE: AVIENCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Avience Biomedicals Ltd: key numbers

Share price
₹270.70
Market cap
₹148.5 Cr
Revenue (annual)
₹52.51 Cr
Net profit (annual)
₹8.75 Cr
P/E (TTM)
17.0×Sector 52.0×
Promoter holding
64.59%
FII holding
0.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Avience Biomedicals Ltd

All →

Other annual general meeting announcements

All →